Condition

SLE - Systemic Lupus Erythematosus clinical trials and research

• 9Clinical trials
• 1New in 30 days
• 5Countries

Newest SLE - Systemic Lupus Erythematosus clinical trials

All recruiting trials (9)

• SLE Registry in Pakistan to understand how lupus presents and progresses

  This project is building a Pakistan lupus registry to see how SLE shows up and changes over time in adults, starting at Fauji Foundation Hospital Rawalpindi.

  Recruiting Foundation University Islamabad · Rawalpindi, Punjab Province · NCT07902622

• FT819 in Lupus Nephritis: a targeted cell therapy trial for moderate-to-severe LN

  This trial tests whether FT819, a donor-derived CAR T cell therapy, can help people with difficult-to-treat lupus nephritis who have not responded to other medicines.

  Recruiting at 12 sites Phase 2 Fate Therapeutics · Beverly Hills, California and 11 other locations · NCT07570862

• IASO-782 for Systemic Lupus Erythematosus

  A small, early-stage trial tests whether IASO-782 is safe and tolerable for adults with SLE, using a randomized, placebo-controlled design.

  Recruiting at 4 sites Phase 1 Nanjing IASO Biotechnology Co., Ltd. · Hangzhou, Zhejiang and 3 other locations · NCT07483346

• Dual-target CAR T therapy (CD19 and BCMA) for relapsed or treatment-resistant autoimmune diseases

  This will try a single infusion of off-the-shelf (allogeneic) CAR T-cells that target CD19 and BCMA in adults whose autoimmune disease has relapsed or not responded to other treatments.

  Recruiting Phase 1 Institute of Hematology & Blood Diseases Hospital, China · Tianjin · NCT07315087

• Umbilical cord blood CAR-T therapy for refractory systemic lupus erythematosus

  This will test an off-the-shelf umbilical cord blood–derived CAR‑T cell therapy targeting CD19 and BCMA to see if it helps adults with treatment‑resistant SLE.

  Recruiting Early Phase 1 Chengdu Ucello Biotechnology Co., Ltd. · Yancheng, Jiangsu and 1 other locations · NCT07274059

• CC312 for relapsed or treatment‑resistant lupus, inflammatory myopathies, and systemic sclerosis

  This early-phase test will try CC312 to see if it is safe and may help adults aged 18–65 with relapsed or treatment‑resistant systemic lupus erythematosus, idiopathic inflammatory myopathies, or systemic sclerosis.

  Recruiting Early Phase 1 CytoCares Inc · Deyang, Sichuan · NCT07193810

• CC312 for adults with moderate to severe lupus

  This Phase 1 trial will test whether CC312 is safe and shows early benefit in adults with moderate to severe lupus.

  Recruiting Phase 1 CytoCares Inc · Chengdu, Sichuan · NCT07177911

• Belimumab and the long-term course of lupus

  This study will see if belimumab lowers the risk of new major organ flares in adults with active systemic lupus compared with standard care.

  Recruiting Biomedical Research Foundation, Academy of Athens · Athens, Attica · NCT07056621

• Treatment for patients with refractory systemic lupus erythematosus using MB-CART19.1

  This study is testing a new treatment called MB-CART19.1 to see if it can help people with tough-to-treat systemic lupus erythematosus feel better.

  Recruiting at 2 sites Phase 1/2 Miltenyi Biomedicine GmbH · Erlangen and 2 other locations · NCT06189157

Related topics

Quick answers

How many SLE - Systemic Lupus Erythematosus clinical trials are recruiting right now?

9, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in China (5 trials), Germany (1 trial), Pakistan (1 trial), Greece (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Early Phase 1: 2, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →